IP Library › Granted Patent US 12,006,333
Granted Patent B2
US 12,006,333 · App. 18/178,189 · Granted Jun 11, 2024

Organic electroluminescent materials and devices comprising imidazole-containing metal complexes

Inventors: Scott Beers (Flemington, NJ); Woo-Young So (Richboro, PA); Hsiao-Fan Chen (Lawrence Township, NJ)
C07F15/006C07F15/0033C07F15/0086H10K59/12H10K85/342H10K85/346H10K85/40H10K85/622H10K85/654H10K85/6572H10K85/6576H10K50/11H10K2101/10H10K2101/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,006,333
App. No.
18/178,189
Granted
Jun 11, 2024
Kind
B2
Abstract

A compound comprising a first ligand L A of Formula I or Formula II: wherein A 1 and A 2 are each independently C or Si; wherein each R A , and R B independently represents mono to the maximum allowable substitution, or no substitution; wherein each X 1 , X 2 , and X 3 is independently C or N; wherein each R, R 1 , R 2 , R 3 , R 4 and R A is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein L A is complexed to a metal M; wherein M is optionally coordinated to one or more other ligands; wherein the ligand L A is optionally linked with the one or more other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand; and wherein any two substituents are optionally joined or fused together to form a ring.

Claims (661)

1. A compound comprising a first ligand L A of Formula I:

wherein A 1 and A 2 are each independently C or Si;

wherein each R A independently represents mono to the maximum allowable substitution, or no substitution;

wherein each R, R 1 , R 2 , R 3 , R 4 and R A is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;

wherein L A is complexed to a metal M;

wherein M is optionally coordinated to one or more other ligands;

wherein the ligand L A is optionally linked with the one or more other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand; and

wherein any two adjacent substituents are optionally joined or fused together to form a ring.

2. The compound of claim 1 , wherein each R, R 1 , R 2 , R 3 , R 4 and R A is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.

3. The compound of claim 1 , wherein A 1 and A 2 are each C.

4. The compound of claim 1 , wherein R 1 , R 2 , R 3 , and R 4 are each independently selected from the group consisting of hydrogen and alkyl.

5. The compound of claim 1 , wherein R is selected from the group consisting of hydrogen, alkyl, and aryl.

6. The compound of claim 1 , wherein M is Pt, Pd, or Jr.

7. The compound of claim 1 , wherein the first ligand L A is selected from the group consisting of:

8. The compound of claim 1 , wherein the first ligand L A is selected from the group consisting of L A1 -L A64 ;

wherein of L A1 -L A36 are ligands of Formula III:

wherein A 1 , A 2 , R, R A , R 1 , R 2 , R 3 , R 4 are defined aS follows:

L A

R

A 1

R 1

R 2

A 2

R 3

R 4

R A

L A1

2,6-di-iPr—Ph

C

CH 3

CH 3

C

CH 3

CH 3

H

L A2

2,6-di-iPr—Ph

C

CH 3

CH 3

C

CH 3

CH 3

2,6-di-iPr—Ph

L A3

H

C

CH 3

CH 3

C

CH 3

CH 3

2,6-di-iPr—Ph

L A4

H

C

CH 3

CH 3

C

CH 3

CH 3

H

L A5

H

Si

CH 3

CH 3

C

CH 3

CH 3

H

L A6

2,6-di-iPr—Ph

Si

CH 3

CH 3

C

CH 3

CH 3

H

L A7

2,6-di-iPr—Ph

Si

isopropyl

isopropyl

C

CH 3

CH 3

H

L A8

H

Si

CH 3

CH 3

C

CH 3

CH 3

H

L A9

H

Si

CH 3

CH 3

C

CH 3

CH 3

2,6-di-iPr—Ph

L A10

2,6-di-iPr—Ph

Si

CH 3

CH 3

C

CH 3

CH 3

2,6-di-iPr—Ph

L A11

H

Si

isopropyl

isopropyl

C

CH 3

CH 3

H

L A12

H

Si

CH 3

CH 3

C

CH 3

CH 3

2,6-di-iPr—Ph

L A13

H

C

CH 3

CH 3

Si

CH 3

CH 3

H

L A14

H

C

CH 3

CH 3

Si

CH 3

CH 3

2,6-di-iPr—Ph

L A15

2,6-di-iPr—Ph

C

CH 3

CH 3

Si

CH 3

CH 3

2,6-di-iPr—Ph

L A16

2,6-di-iPr—Ph

C

CH 3

CH 3

Si

CH 3

CH 3

H

L A17

H

C

CH 3

CH 3

Si

i-Pr

i-Pr

H

L A18

H

C

CH 3

CH 3

Si

i-Pr

i-Pr

2,6-di-iPr—Ph

L A19

2,6-di-iPr—Ph

C

CH 3

CH 3

Si

i-Pr

i-Pr

2,6-di-iPr—Ph

L A20

H

C

CD 3

CD 3

C

CD 3

CD 3

H

L A21

H

C

CD 3

CD 3

C

CD 3

CD 3

2,6-di-iPr—Ph

L A22

Phenyl

C

CD 3

CD 3

C

CD 3

CD 3

H

L A23

H

C

CD 3

CD 3

C

CD 3

CD 3

Phenyl

L A24

2,6-di-iPr—Ph

C

CD 3

CD 3

C

CD 3

CD 3

H

L A25

H

C

CD 3

CD 3

C

CD 3

CD 3

isopropyl

L A26

H

C

CD 3

CD 3

Si

CH 3

CH 3

H

L A27

H

C

CD 3

CD 3

Si

CD 3

CD 3

H

L A28

Phenyl

C

CH 3

CH 3

C

CH 3

CH 3

H

L A29

Phenyl

C

CD 3

CD 3

Si

CH 3

CH 3

H

L A30

Phenyl

Si

CH 3

CH 3

C

CD 3

CD 3

Phenyl

L A31

H

Si

isopropyl

isopropyl

C

CH 3

CH 3

Phenyl

L A32

H

C

CD 3

CD 3

Si

CH 3

CH 3

t-Butyl

L A33

Phenyl

C

CH 3

CH 3

C

CH 3

CH 3

t-Butyl

L A34

Phenyl

C

CD 3

CD 3

Si

isopropyl

isopropyl

isopropyl

L A35

Phenyl

Si

CD 3

CD 3

C

CD 3

CD 3

t-Butyl

L A36

H

Si

CD 3

CD 3

C

CD 3

CD 3

t-Butyl

wherein of L A37 -L A64 are ligands of Formula IV:

wherein A 1 , A 2 , R, R A , R 1 , R 2 , R 3 , and R 4 are defined as follows:

L A

R

A 1

R 1

R 2

A 2

R 3

R 4

R A

L A37

H

C

CH 3

CH 3

C

CH 3

CH 3

CH 3

L A38

Phenyl

C

CH 3

CH 3

C

CH 3

CH 3

CH 3

L A39

2,6-di-

C

CH 3

CH 3

C

CH 3

CH 3

CH 3

iPr—Ph

L A40

CD 3

C

CH 3

CH 3

C

CH 3

CH 3

CH 3

L A41

H

C

CD 3

CD 3

C

CD 3

CD 3

CD 3

L A42

Phenyl

C

CD 3

CD 3

C

CD 3

CD 3

CD 3

L A43

2,6-di-

C

CD 3

CD 3

C

CD 3

CD 3

CD 3

iPr—Ph

L A44

CD 3

C

CD 3

CD 3

C

CD 3

CD 3

CD 3

L A45

H

C

CH 3

CH 3

Si

CH 3

CH 3

CH 3

L A46

Phenyl

C

CH 3

CH 3

Si

CH 3

CH 3

CH 3

L A47

2,6-di-

C

CH 3

CH 3

Si

CH 3

CH 3

CH 3

iPr—Ph

L A48

CD 3

C

CH 3

CH 3

Si

CH 3

CH 3

CH 3

L A49

H

C

CD 3

CD 3

Si

CH 3

CH 3

CH 3

L A50

Phenyl

C

CD 3

CD 3

Si

CH 3

CH 3

CH 3

L A51

2,6-di-

C

CD 3

CD 3

Si

CH 3

CH 3

CH 3

iPr—Ph

L A52

CD 3

C

CD 3

CD 3

Si

CH 3

CH 3

CH 3

L A53

H

Si

CH 3

CH 3

C

CH 3

CH 3

CH 3

L A54

Phenyl

Si

CH 3

CH 3

C

CH 3

CH 3

CH 3

L A55

2,6-di-

Si

CH 3

CH 3

C

CH 3

CH 3

CH 3

iPr—Ph

L A56

CD 3

Si

CH 3

CH 3

C

CH 3

CH 3

CH 3

L A57

H

Si

CH 3

CH 3

C

CD 3

CD 3

CD 3

L A58

Phenyl

Si

CH 3

CH 3

C

CD 3

CD 3

CD 3

L A59

2,6-di-

Si

CH 3

CH 3

C

CD 3

CD 3

CD 3

iPr—Ph

L A60

CD 3

Si

CH 3

CH 3

C

CD 3

CD 3

CD 3

L A61

H

Si

isopropyl

isopropyl

C

CH 3

CH 3

CH 3

L A62

Phenyl

Si

isopropyl

isopropyl

C

CH 3

CH 3

CH 3

L A63

2,6-di-

Si

isopropyl

isopropyl

C

CH 3

CH 3

CH 3

iPr—Ph

L A64

CD 3

Si

isopropyl

isopropyl

C

CH 3

CH 3

CH 3

and wherein 2,6-di-iPr-Ph is

9. The compound of claim 8 wherein the compound is the Compound Ax having the formula Ir(L Ai ) 3 ; or the Compound By having the formula Ir(L Ai )(L Bk ) 2 ;

wherein x=i and y=468i+k−468;

wherein i is an integer from 1 to 64 and k is an integer from 1 to 468;

wherein L Bk is selected from the group consisting of the following structures:

10. The compound of claim 1 , wherein the compound has a formula of M(L A ) x (L B ) y (L C ) z wherein L B and L C are each a bidentate ligand; and wherein x is 1, 2, or 3; y is 0, 1, or 2; z is 0, 1, or 2; and x+y+z is the oxidation state of the metal M.

11. The compound of claim 10 , wherein the compound has a formula selected from the group consisting of Ir(L A ) 3 , Ir(L A )(L B ) 2 , Ir(L A ) 2 (L B ), Ir(L A )(L B )(L C ), wherein L A , L B , and L C are different from each other; or the compound has a formula of Pt(L A )(L B ), wherein L A and L B are the same or different.

12. The compound of claim 10 , wherein L B and L C are each independently selected from the group consisting of:

wherein each Y 1 to Y 13 is independently selected from the group consisting of carbon and nitrogen;

wherein Y′ is selected from the group consisting of BR e , NR e , PR e , O, S, Se, C═O, S═O, SO 2 , CR e R f , SiR e R f , and GeR e R f ;

wherein R e and R f are optionally fused or joined to form a ring;

wherein each R a , R b , R c , and R d independently represents from mono substitution to the maximum possible number of substitution, or no substitution;

wherein each R a , R b , R c , R d , R e and R f is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and

wherein any two adjacent substituents of R a , R b , R c , and R d are optionally fused or joined to form a ring or form a multidentate ligand.

13. An organic light emitting device (OLED) comprising:

an anode;

a cathode; and

an organic layer, disposed between the anode and the cathode, comprising a compound comprising a first ligand L A of Formula I:

wherein A 1 and A 2 are each independently C or Si;

wherein each R A independently represents mono to the maximum allowable substitution, or no substitution;

wherein each R, R 1 , R 2 , R 3 , R 4 and R A is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof,

wherein L A is complexed to a metal M;

wherein M is optionally coordinated to one or more other ligands;

wherein the ligand L A is optionally linked with the one or more other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand; and

wherein any two adjacent substituents are optionally joined or fused together to form a ring.

14. The OLED of claim 13 , wherein the organic layer further comprises a host, wherein the host comprises at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.

15. The OLED of claim 14 , wherein the host is selected from the group consisting of:

and combinations thereof.

16. A consumer product comprising an organic light-emitting device (OLED) comprising:

an anode;

a cathode; and

an organic layer, disposed between the anode and the cathode, comprising a compound comprising a first ligand L A of Formula I:

wherein A 1 and A 2 are each independently C or Si;

wherein each R A independently represents mono to the maximum allowable substitution, or no substitution;

wherein each R, R 1 , R 2 , R 3 , R 4 and R A is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof,

wherein L A is complexed to a metal M;

wherein M is optionally coordinated to one or more other ligands;

wherein the ligand L A is optionally linked with the one or more other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand; and

wherein any two adjacent substituents are optionally joined or fused together to form a ring.

17. The consumer product of claim 16 , wherein the consumer product is selected from the group consisting of a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for interior or exterior illumination and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cell phone, tablet, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a micro-display that is less than 2 inches diagonal, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall comprising multiple displays tiled together, a theater or stadium screen, a light therapy device, and a sign.

18. A formulation comprising a compound of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2024
From: BEERS, SCOTT; SO, WOO-YOUNG; CHEN, HSIAO-FAN
To: UNIVERSAL DISPLAY CORPORATION
Reel/Frame 066280/0504 →
Continuity (3)
Continuation 16854193 · Apr 21, 2020
Provisional Application 62840625 · Apr 30, 2019
Related Publication 20230203076A1 · Jun 29, 2023